Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 135

1.

Alcohol use disorders: screening and diagnosis.

Maisto SA, Saitz R.

Am J Addict. 2003;12 Suppl 1:S12-25. Review.

PMID:
14972777
2.

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

Fudala PJ, Bridge TP, Herbert S, Williford WO, Chiang CN, Jones K, Collins J, Raisch D, Casadonte P, Goldsmith RJ, Ling W, Malkerneker U, McNicholas L, Renner J, Stine S, Tusel D; Buprenorphine/Naloxone Collaborative Study Group.

N Engl J Med. 2003 Sep 4;349(10):949-58.

3.

Office-based practice and opioid-use disorders.

Clark HW.

N Engl J Med. 2003 Sep 4;349(10):928-30. No abstract available.

PMID:
12954740
4.

Use of buprenorphine in pregnancy: patient management and effects on the neonate.

Johnson RE, Jones HE, Fischer G.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S87-101. Review.

PMID:
12738353
5.

Buprenorphine: how to use it right.

Johnson RE, Strain EC, Amass L.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S59-77. Review.

PMID:
12738351
6.

[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].

Loustauneau A, Auriacombe M, Daulouede JP, Tignol J.

Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S31-6. Review. French.

PMID:
12518080
7.

Heroin detoxification with buprenorphine on an inpatient psychiatric unit.

DiPaula BA, Schwartz R, Montoya ID, Barrett D, Tang C.

J Subst Abuse Treat. 2002 Oct;23(3):163-9.

8.

Clinical practice. Office-based treatment of opioid-dependent patients.

Fiellin DA, O'Connor PG.

N Engl J Med. 2002 Sep 12;347(11):817-23. Review. No abstract available.

PMID:
12226153
9.

Abstinence reinforcement maintenance contingency and one-year follow-up.

Preston KL, Umbricht A, Epstein DH.

Drug Alcohol Depend. 2002 Jul 1;67(2):125-37.

PMID:
12095662
10.

Urine drug screening in adolescents.

Casavant MJ.

Pediatr Clin North Am. 2002 Apr;49(2):317-27. Review.

PMID:
11993285
11.

[Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases].

Lejeune C, Aubisson S, Simmat-Durand L, Cneude F, Piquet M, Gourarier L; Groupe d'Etudes Grossesse et addictions.

Ann Med Interne (Paris). 2001 Nov;152 Suppl 7:21-7. French.

PMID:
11965095
12.

Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.

Strain EC, Walsh SL, Bigelow GE.

Psychopharmacology (Berl). 2002 Jan;159(2):161-6. Epub 2001 Oct 12.

PMID:
11862344
13.

Effect of opioid dependence pharmacotherapies on zidovudine disposition.

McCance-Katz EF, Rainey PM, Friedland G, Kosten TR, Jatlow P.

Am J Addict. 2001 Fall;10(4):296-307.

PMID:
11783744
14.

Urine drug screening in the medical setting.

Hammett-Stabler CA, Pesce AJ, Cannon DJ.

Clin Chim Acta. 2002 Jan;315(1-2):125-35. Review.

PMID:
11728415
15.

Office-based treatment for opioid dependence: reaching new patient populations.

Fiellin DA, Rosenheck RA, Kosten TR.

Am J Psychiatry. 2001 Aug;158(8):1200-4. No abstract available.

PMID:
11481150
16.

Effects of buprenorphine/naloxone in opioid-dependent humans.

Stoller KB, Bigelow GE, Walsh SL, Strain EC.

Psychopharmacology (Berl). 2001 Mar;154(3):230-42.

PMID:
11351930
17.

A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence.

Barnett PG, Rodgers JH, Bloch DA.

Addiction. 2001 May;96(5):683-90.

PMID:
11331027
18.

Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans.

Comer SD, Collins ED, Fischman MW.

Psychopharmacology (Berl). 2001 Feb;154(1):28-37.

PMID:
11292003
19.

Hepatitis after intravenous buprenorphine misuse in heroin addicts.

Berson A, Gervais A, Cazals D, Boyer N, Durand F, Bernuau J, Marcellin P, Degott C, Valla D, Pessayre D.

J Hepatol. 2001 Feb;34(2):346-50.

PMID:
11281569
20.

Injecting misuse of buprenorphine among French drug users.

Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti JP.

Addiction. 2001 Feb;96(2):267-72.

PMID:
11182872

Supplemental Content

Support Center